Healthcare provider profile · identity verified

Hong Li, MD

Internal Medicine · BRAINERD, MN · NPI 1164407466

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	716	173
Atorvastatin Calcium	Atorvastatin Calcium	432	126
Amlodipine Besylate	Amlodipine Besylate	386	108
Omeprazole	Omeprazole	348	87
Losartan Potassium	Losartan Potassium	325	79
Metoprolol Succinate	Metoprolol Succinate	313	90
Eliquis	Apixaban	301	64
Lisinopril	Lisinopril	295	74
Gabapentin	Gabapentin	264	81
Trazodone Hcl	Trazodone Hcl	237	73
Rosuvastatin Calcium	Rosuvastatin Calcium	228	71
Metformin Hcl Er	Metformin Hcl	209	61
Pantoprazole Sodium	Pantoprazole Sodium	193	49
Simvastatin	Simvastatin	173	59
Carvedilol	Carvedilol	172	40
Furosemide	Furosemide	171	47
Potassium Chloride	Potassium Chloride	169	58
Alendronate Sodium	Alendronate Sodium	143	40
Metoprolol Tartrate	Metoprolol Tartrate	143	40
Warfarin Sodium	Warfarin Sodium	139	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	124	39
Escitalopram Oxalate	Escitalopram Oxalate	123	33
Hydrochlorothiazide	Hydrochlorothiazide	120	38
Atenolol	Atenolol	106	31
Hydralazine Hcl	Hydralazine Hcl	101	18
Metformin Hcl	Metformin Hcl	101	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	100	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	93	21
Tamsulosin Hcl	Tamsulosin Hcl	93	25
Fluticasone Propionate	Fluticasone Propionate	91	31
Allopurinol	Allopurinol	89	20
Bupropion Xl	Bupropion Hcl	87	22
Xarelto	Rivaroxaban	86	18
Famotidine	Famotidine	85	28
Tramadol Hcl	Tramadol Hcl	84	21
Torsemide	Torsemide	80	27
Duloxetine Hcl	Duloxetine Hcl	75	17
Clopidogrel	Clopidogrel Bisulfate	74	24
Pravastatin Sodium	Pravastatin Sodium	71	21
Venlafaxine Hcl Er	Venlafaxine Hcl	69	15
Mirtazapine	Mirtazapine	68	19
Prednisone	Prednisone	64	33
Estradiol	Estradiol	60	22
Montelukast Sodium	Montelukast Sodium	59	16
Sertraline Hcl	Sertraline Hcl	59	12
Tizanidine Hcl	Tizanidine Hcl	58	13
Cefdinir	Cefdinir	56	49
Citalopram Hbr	Citalopram Hydrobromide	56	14
Januvia	Sitagliptin Phosphate	56	12
Ventolin Hfa	Albuterol Sulfate	56	19
Synthroid	Levothyroxine Sodium	53	12
Doxycycline Hyclate	Doxycycline Hyclate	52	43
Propranolol Hcl	Propranolol Hcl	52	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	16
Nifedipine Er	Nifedipine	50	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	14
Lorazepam	Lorazepam	47	16
Clonazepam	Clonazepam	46	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	46	43
Albuterol Sulfate Hfa	Albuterol Sulfate	45	20
Amoxicillin	Amoxicillin	44	30
Labetalol Hcl	Labetalol Hcl	44	suppressed
Terazosin Hcl	Terazosin Hcl	41	suppressed
Verapamil Er	Verapamil Hcl	40	suppressed
Celecoxib	Celecoxib	39	20
Zolpidem Tartrate	Zolpidem Tartrate	39	15
Chlorthalidone	Chlorthalidone	38	suppressed
Valsartan	Valsartan	38	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	37	suppressed
Azithromycin	Azithromycin	36	32
Donepezil Hcl	Donepezil Hcl	35	suppressed
Ipratropium Bromide	Ipratropium Bromide	35	12
Meloxicam	Meloxicam	34	12
Valacyclovir	Valacyclovir Hcl	34	19
Spironolactone	Spironolactone	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	11
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Midodrine Hcl	Midodrine Hcl	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Jardiance	Empagliflozin	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Dulera	Mometasone/Formoterol	18	suppressed
Topiramate	Topiramate	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lacosamide	Lacosamide	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Finasteride	Finasteride	15	suppressed
Nitroglycerin	Nitroglycerin	15	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Clonidine	Clonidine	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Modafinil	Modafinil	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nateglinide	Nateglinide	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Novolog Flexpen	Insulin Aspart	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Baclofen	Baclofen	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error